Concord Biotech Market Cap

Concord Biotech has a market cap or net worth of 147.34 billion as of December 5, 2025. Its market cap has decreased by -26.45% in one year.

Market Cap

147.34B

Enterprise Value

144.04B

Revenue

11.25B

Ranking

n/a

PE Ratio

45.59

Stock Price

1,408.40

Market Cap Chart

Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 147.34B, an increase of 49.38%. That is a compound annual growth rate of 19.05%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	147.34B	-36.29%
Dec 31, 2024	231.28B	50.21%
Dec 29, 2023	153.97B	56.11%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,362.71B
Divi's Laboratories	1,717.32B
Cipla	1,228.62B
Apollo Hospitals Enterprise	1,035.39B
Zydus Lifesciences	941.58B
Mankind Pharma	910.67B
Aurobindo Pharma	710.38B
Alkem Laboratories	676.62B

Market Cap Rankings